# A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

> **NCT00358553** · PHASE1 · COMPLETED · sponsor: **Baxter Healthcare Corporation**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00358553
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358553, "A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00358553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*